Influence of cell cycle on responses of MCF-7 cells to benzo[a]pyrene

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Hamouchene, Hamza ^a   Arlt, Volker M ^a   Giddings, Ian ^a   Phillips, David H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7,8 DIHYDROXYBENZO[A]PYRENE 9,10 OXIDE; ACTIVATING TRANSCRIPTION FACTOR 3; ALDEHYDE DEHYDROGENASE; BENZO[A]PYRENE; CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DICKKOPF 1 PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; GLUCURONOSYLTRANSFERASE 1A6; GLUTATHIONE TRANSFERASE M1; GROWTH DIFFERENTIATION FACTOR 15; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 4; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOPHOSMIN; PROTEIN BAX; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; PUMA PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR E2F6; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; CELL CYCLE PROTEIN; CYTOCHROME P 450 CYP1B1; CYTOCHROME P-450 CYP1B1; UNSPECIFIC MONOOXYGENASE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA ADDUCT; DNA BINDING; DNA DAMAGE; DNA REPAIR; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; XENOBIOTIC METABOLISM; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; PRINCIPAL COMPONENT ANALYSIS; TUMOR CELL LINE;

ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CATENINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 79959633497     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-333     Document Type: Article

References (63)

1. Miller EC. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer Res 1978, 38(6):1479-1496.
2. Miller EC, Miller JA. Milestones in chemical carcinogenesis. Semin Oncol 1979, 6(4):445-460.
3. Gooderham NJaC PL. Mechanisms of chemical carcinogenesis. 2002, 1.
4. Phillips DH. Fifty years of benzo(a)pyrene. Nature 1983, 303(5917):468-472. 10.1038/303468a0, 6304528.
5. Gu YZ, Hogenesch JB, Bradfield CA. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000, 40:519-561. 10.1146/annurev.pharmtox.40.1.519, 10836146.
6. Crews ST, Fan CM. Remembrance of things PAS: regulation of development by bHLH-PAS proteins. Curr Opin Genet Dev 1999, 9(5):580-587. 10.1016/S0959-437X(99)00003-9, 10508688.
7. Khan QA, Dipple A. Diverse chemical carcinogens fail to induce G(1) arrest in MCF-7 cells. Carcinogenesis 2000, 21(8):1611-1618. 10.1093/carcin/21.8.1611, 10910966.
8. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009, 77(4):713-722. 10.1016/j.bcp.2008.08.031, 2657192, 18817753.
9. Hockley SL, Arlt VM, Brewer D, Giddings I, Phillips DH. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics 2006, 7:260. 10.1186/1471-2164-7-260, 1621085, 17042939.
10. Hockley SL, Arlt VM, Brewer D, Te Poele R, Workman P, Giddings I, Phillips DH. AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. Chem Res Toxicol 2007, 20(12):1797-1810. 10.1021/tx700252n, 17944540.
11. Jiao H, Allinson SL, Walsh MJ, Hewitt R, Cole KJ, Phillips DH, Martin FL. Growth kinetics in MCF-7 cells modulate benzo[a]pyrene-induced CYP1A1 up-regulation. Mutagenesis 2007, 22(2):111-116. 10.1093/mutage/gel060, 17237483.
12. Levine-Fridman A, Chen L, Elferink CJ. Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity. Mol Pharmacol 2004, 65(2):461-469. 10.1124/mol.65.2.461, 14742689.
13. Santini RP, Myrand S, Elferink C, Reiners JJ. Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase. J Pharmacol Exp Ther 2001, 299(2):718-728.
14. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008, 8(5):387-398. 10.1038/nrc2389, 18432252.
15. Weiss C, Bohmann D. Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell Cycle 2004, 3(2):111-113.
16. Thiel G, Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 2002, 193(3):287-292. 10.1002/jcp.10178, 12384981.
17. Yin X, Dewille JW, Hai T. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene 2008, 27(15):2118-2127. 10.1038/sj.onc.1210861, 17952119.
18. Strelau J, Schmeer C, Peterziel H, Sackmann T, Herold-Mende C, Steiner H, Weller M, Unsicker K. Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines. Cancer Lett 2008, 270(1):30-39. 10.1016/j.canlet.2008.04.042, 18550273.
19. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009, 47(9):1304-1309. 10.1016/j.freeradbiomed.2009.07.035, 2763938, 19666107.
20. Shtivelman E, Sussman J, Stokoe D. A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol 2002, 12(11):919-924. 10.1016/S0960-9822(02)00843-6, 12062056.
21. Matsuoka M, Sudo H, Tsuji K, Sato H, Kurita M, Suzuki H, Nishimoto I, Ogata E. ik3-2, a relative to ik3-1/Cables, is involved in both p53-mediated and p53-independent apoptotic pathways. Biochem Biophys Res Commun 2003, 312(2):520-529. 10.1016/j.bbrc.2003.10.142, 14637168.
22. Tsang WY, Wang L, Chen Z, Sanchez I, Dynlacht BD. SCAPER, a novel cyclin A-interacting protein that regulates cell cycle progression. J Cell Biol 2007, 178(4):621-633. 10.1083/jcb.200701166, 2064469, 17698606.
23. van Delft JH, van Agen E, van Breda SG, Herwijnen MH, Staal YC, Kleinjans JC. Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis 2004, 25(7):1265-1276. 10.1093/carcin/bgh108, 14963013.
24. Bartosiewicz M, Penn S, Buckpitt A. Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ Health Perspect 2001, 109(1):71-74. 10.1289/ehp.0110971, 1242054, 11171528.
25. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, Bennett L, Tennant R, Stoll R, Barrett JC, Blanchard K, Paules RS, Afshari CA. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 2002, 67(2):219-231. 10.1093/toxsci/67.2.219, 12011481.
26. Chen H, Liu J, Merrick BA, Waalkes MP. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinog 2001, 30(2):79-87. 10.1002/1098-2744(200102)30:2<79::AID-MC1016>3.0.CO;2-F, 11241755.
27. Newton RK, Aardema M, Aubrecht J. The utility of DNA microarrays for characterizing genotoxicity. Environ Health Perspect 2004, 112(4):420-422. 10.1289/ehp.6709, 1241894, 15033590.
28. Mitchell KA, Elferink CJ. Timing is everything: consequences of transient and sustained AhR activity. Biochem Pharmacol 2009, 77(6):947-956. 10.1016/j.bcp.2008.10.028, 2751579, 19027718.
29. Chang CY, Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 1998, 18(1):525-535. 121520, 9418899.
30. Ikuta T, Kobayashi Y, Kawajiri K. Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem 2004, 279(18):19209-19216. 10.1074/jbc.M310492200, 14985336.
31. Jeffy BD, Chen EJ, Gudas JM, Romagnolo DF. Disruption of cell cycle kinetics by benzo[a]pyrene: inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2. Neoplasia 2000, 2(5):460-470. 10.1038/sj.neo.7900104, 1507983, 11191113.
32. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004, 432(7015):316-323. 10.1038/nature03097, 15549093.
33. Nakanishi M, Shimada M, Niida H. Genetic instability in cancer cells by impaired cell cycle checkpoints. Cancer Sci 2006, 97(10):984-989. 10.1111/j.1349-7006.2006.00289.x, 16925578.
34. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51(23 Pt 1):6304-6311.
35. Massague J. G1 cell-cycle control and cancer. Nature 2004, 432(7015):298-306. 10.1038/nature03094, 15549091.
36. Khan QA, Dipple A, Anderson LM. Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells. Mol Carcinog 2002, 33(1):1-8. 10.1002/mc.10013, 11807952.
37. Jiao S, Liu B, Gao A, Ye M, Jia X, Zhang F, Liu H, Shi X, Huang C. Benzo(a)pyrene-caused increased G1-S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblasts. Toxicol Lett 2008, 178(3):167-175. 10.1016/j.toxlet.2008.03.012, 18448277.
38. Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY, Shieh SY. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J 2007, 26(17):3968-3980. 10.1038/sj.emboj.7601825, 1994125, 17690688.
39. Long DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res 2000, 60(21):5913-5915.
40. Anwar A, Dehn D, Siegel D, Kepa JK, Tang LJ, Pietenpol JA, Ross D. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem 2003, 278(12):10368-10373. 10.1074/jbc.M211981200, 12529318.
41. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004, 279(23):23847-23850. 10.1074/jbc.R400004200, 15028720.
42. Duriez C, Moyret-Lalle C, Falette N, El-Ghissassi F, Puisieux A. BTG2, its family and its tutor. Bull Cancer 2004, 91(7-8):E242-253.
43. Wade PA. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet 2001, 10(7):693-698. 10.1093/hmg/10.7.693, 11257101.
44. Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 1998, 19(10):1847-1853. 10.1093/carcin/19.10.1847, 9806168.
45. Williams JA, Martin FL, Muir GH, Hewer A, Grover PL, Phillips DH. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 2000, 21(9):1683-1689. 10.1093/carcin/21.9.1683, 10964100.
46. McFadyen MC, Melvin WT, Murray GI. Cytochrome P450 CYP1B1 activity in renal cell carcinoma. Br J Cancer 2004, 91(5):966-971. 2409861, 15280921.
47. Wu MF, Wu WJ, Chang GC, Chen CY, Hu SW, Tsai WT, Lee H, Lin P. Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. Toxicol Lett 2004, 150(2):211-219. 10.1016/j.toxlet.2004.01.006, 15093676.
48. Buters JT, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, Gonzalez FJ. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 1999, 96(5):1977-1982. 10.1073/pnas.96.5.1977, 26722, 10051580.
49. Keshava C, Whipkey D, Weston A. Transcriptional signatures of environmentally relevant exposures in normal human mammary epithelial cells: benzo[a]pyrene. Cancer Lett 2005, 221(2):201-211. 10.1016/j.canlet.2004.08.037, 15808406.
50. Burczynski ME, Lin HK, Penning TM. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res 1999, 59(3):607-614.
51. Penning TM, Burczynski ME, Hung CF, McCoull KD, Palackal NT, Tsuruda LS. Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem Res Toxicol 1999, 12(1):1-18. 10.1021/tx980143n, 9894013.
52. Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 2006, 21(4):257-276. 10.2133/dmpk.21.257, 16946553.
53. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001, 81(2):807-869.
54. Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer 2006, 6(7):493-505. 10.1038/nrc1885, 16794633.
55. Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 2004, 5(10):792-804. 10.1038/nrm1493, 15459660.
56. Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008, 134(3):451-460. 10.1016/j.cell.2008.06.028, 2758522, 18692468.
57. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006, 12(9):440-450. 10.1016/j.molmed.2006.07.007, 16899408.
58. Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J. RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest. Oncogene 2007, 26(8):1110-1121. 10.1038/sj.onc.1210148, 17146433.
59. http://www.facslab.toxikologie.uni-mainz.de/engl.%20Websites/Downloads-engl.jsp
60. Phillips DH, Arlt VM. The 32P-postlabeling assay for DNA adducts. Nat Protoc 2007, 2(11):2772-2781. 10.1038/nprot.2007.394, 18007613.
61. Phillips DH, Castegnaro M. Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 1999, 14(3):301-315. 10.1093/mutage/14.3.301, 10374998.
62. GEO GEO., http://www.ncbi.nlm.nih.gov/geo/
63. ImageJ ImageJ., http://rsbweb.nih.gov/ij/